![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright © 2006 The Author(s) The spatial arrangement of ORC binding modules determines the functionality of replication origins in budding yeast Department of Biochemistry, Molecular Biology and Biophysics, 6-155 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455, USA *To whom correspondence should be addressed. Tel: +1 612 624 2469; Fax: +1 612 625 2163; Email: bieli003/at/umn.edu Received June 2, 2006; Revised August 22, 2006; Accepted August 28, 2006. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract In the quest to define autonomously replicating sequences (ARSs) in eukaryotic cells, an ARS consensus sequence (ACS) has emerged for budding yeast. This ACS is recognized by the replication initiator, the origin recognition complex (ORC). However, not every match to the ACS constitutes a replication origin. Here, we investigated the requirements for ORC binding to origins that carry multiple, redundant ACSs, such as ARS603. Previous studies raised the possibility that these ACSs function as individual ORC binding sites. Detailed mutational analysis of the two ACSs in ARS603 revealed that they function in concert and give rise to an initiation pattern compatible with a single bipartite ORC binding site. Consistent with this notion, deletion of one base pair between the ACS matches abolished ORC binding at ARS603. Importantly, loss of ORC binding in vitro correlated with the loss of ARS activity in vivo. Our results argue that replication origins in yeast are in general comprised of bipartite ORC binding sites that cannot function in random alignment but must conform to a configuration that permits ORC binding. These requirements help to explain why only a limited number of ACS matches in the yeast genome qualify as ORC binding sites. INTRODUCTION Although the mechanism underlying the initiation of DNA synthesis differs across species, a general theme has emerged to describe the activation of the replication process in prokaryotes, animal viruses and simple eukaryotes. The recognition of a binding site with multiple sequence elements is a key factor for the initiation of DNA replication in a number of organisms (1). For many of these sites, the spacing between sequence elements is crucial for the binding of the replication initiator and the subsequent initiation of DNA synthesis (2). It has been shown, for instance, that exact spacing of the bipartite initiator binding site is necessary for replication from oriP in Epstein-Barr virus (3) and the simian virus (SV) 40 origin (4). The situation in eukaryotic cells is less well defined, as replication initiates from multiple start sites distributed along chromosomes and the search for origin sequences, especially in the genomes of mammalian cells, has proven difficult, with only a few well-studied examples (5). Saccharomyces cerevisiae remains the eukaryotic system in which replication origins are best understood. Origin sequences were first identified as autonomously replicating sequences (ARSs) by their ability to promote replication of plasmid DNA (6–8). ARSs carry multiple matches to an AT-rich, 11 bp ARS consensus sequence (ACS), 5′-(A/T) TTTA(C/T)(A/G)TTT(A/T)-3′ (8–10). Substitution mutations scanning origin regions with matches to the ACS have identified multiple functional elements (11–15). Elements that are essential for replication are called A elements, while those that are non-essential are referred to as B elements (14). In ARS1, A and B elements overlap with matches to the ACS (Figure 1A
Footprinting analyses have shown that ORC interacts directly with the ACS (18,22–24). In contrast to origins such as ARS1 and ARS307, which carry a single essential A element, a second class of origins, branded compound origins, has been described (25,26). These consist of multiple ACS matches that appear to serve as redundant ORC binding sites because the origin was still active when one ACS was mutated (26). The best-studied examples for this class are ARS101 (Figure 1C One prediction for compound origins is that they possess multiple, redundant replication start sites (26). Previous mapping studies of ARS1 revealed a single, defined leading strand start site that maps adjacent to the ORC binding site (28,29). For origins with redundant, non-essential ACSs, it is therefore possible that more than one start site for replication exists. However, this has never been directly addressed. To examine the origin structure of an ARS element containing more than one potential ORC binding site, we investigated replication initiation at the origin ARS603. Our studies revealed that replication initiates in close proximity to the ACS matches where ORC binding occurs. The initiation pattern of ARS603 is similar to that of ARS1 (29), suggesting that the two ACSs at ARS603 do not function as individual origins. Because it was previously unknown if a single or multiple ORC complexes occupy the ACSs in compound origins, we employed electrophoretic mobility shift assays (EMSAs) to distinguish between these possibilities. Our results demonstrate that the two ACSs act in concert as a single bipartite ORC binding site and that their spacing and orientation affect ORC binding in vitro and in vivo. While substitution mutations similar to those introduced in earlier studies (27) retained some ORC binding activity, deletion of one ACS abrogated ORC binding. These studies argue that a single ACS is insufficient to define a functional ORC binding site, and we propose the inclusion of bipartite consensus sequences in future algorithms for the identification of replication origins in yeast. The dependence of ORC binding on the spacing of specific recognition sequences identifies another link between origin structure and activation to further our understanding of the DNA replication initiation process. MATERIALS AND METHODS Replication initiation point mapping Replication initiation point (RIP) mapping was performed on the strain SP1 MATa, ura3-52 his3 trp1-289 leu2-2,113 ade8 can1 (14). DNA was isolated by CsCl gradient centrifugation from asynchronously growing cultures, as described (30). As a source for the non-replicating DNA control, DNA was isolated from nocodazole-arrested cells. Approximately 2 μg of isolated DNA was digested with PstI, leaving a 5′ phosphorylated end, and then treated overnight with λ-exonuclease to eliminate nicked DNA (30). The sample was then used as a template for primer extension reactions using radiolabeled primers as described (30). Reactions were fractionated on a polyacrylamide gel next to corresponding sequencing reactions. The sequences for the primers utilized in this study were as follows: 161t (5′-GCTGGGAGAACTATTCTTCCAGAG-3′) for the top strand and 665b (5′-GAGCGATTCTGATGAAACGCACTG-3′) for the bottom strand. In vitro ORC EMSA Binding reactions were performed with DNA fragments generated by PCR using biotin-labeled primers. To reduce variability, one set of biotin-labeled primers (IDT) was used to recognize the flanking regions of the cloning site in the plasmid pSTBlue-1 (Novagen) (31). Annealed oligonucleotides spanning wild-type (WT) or mutant origin sequences of ARS603, ARS101, ARS1 and ARS307 were inserted into this vector. The length of the probes ranged from 81 to 100 bp to include core sequences for each origin (Figure 1 Chromatin immunoprecipitation (ChIP) Strains used for integration of ARS603 into the URA3 locus and mutation of endogenous ARS603 by two-step gene replacement were derivatives of BF264-15DU MATa ura3 ade1 his2 leu2-3,112 trp1-12 Δns (32). For integration at the URA3 locus, 206 bp of ARS603 was ligated into the SacI–SalI cloning region of pRS306. The vector was then linearized with StuI within the URA3 marker and integrated into the chromosomal URA3 locus. Chromatin samples were obtained from asynchronously growing cultures and processed as described (33). ORC-bound fragments were precipitated from pre-cleared chromatin with a mouse, anti-yeast ORC2 monoclonal antibody (RDI) and protein A sepharose beads (Sigma), which were pre-blocked in BSA. Immunoprecipitated DNA fragments were detected by PCR. Primer pairs for the ChIP analysis were specific to the following regions: ARS1: 630 (5′-GTTAGCTGGTGGACTGACGCCAGAAA -3′), 1010 (5′-GCCTGTGAACATTCTCTTCAACAAG-3′); R11: t(5′-CACCGATACGTACTTAAACTCT-3′), b(5′-GAGAAAGCTTAGTCCATTCGGC-3′); ARS603/URA3: pRS2100t (5′-CAGCTTTTGTTCCCTTTAGTGAG-3′), pRS2613b (5′-CACCTCTGACTTGAGCGTCGAT-3′); ARS603: 161t (5′-GCTGGGAGAACTATTCTTCCAGAG-3′), 482b (5′-CTCCTTTGTTAGAGTTAATTTATGATC-3′). Quantitation by particle analysis was performed using the NIH ImageJ program, and fold enrichment was calculated by taking the ratio of immunoprecipitated to input signals for the origin region (ARS1 or ARS603) divided by the same ratio for the non-origin region (R11) as described (34). Plasmid stability assay Origin sequences ~200 bp in length were cloned into pSTBlue-1 (Novagen) unless otherwise indicated. Site-directed mutagenesis reactions were performed according to the Stratagene QuikChange procedure. The sequences were then cloned into the pARS plasmid vector containing the URA3 gene and a centromere (14). Yeast transformations into the SP1 strain (14) were performed with lithium acetate, and cells were plated onto SC–Ura plates. Primary transformants were further streaked out on an additional SC–Ura plate. Yeast cells containing the pARS plasmid with the given origin sequence were grown in SC–Ura medium to early log phase, counted by hemocytometer and plated to assess the initial number of plasmid-containing cells. Approximately 200 cells were released into 2 ml of complete medium for 30 h at 30°C. Cells were counted again, and equal amounts were plated on complete and SC–Ura medium to determine the percent of colonies that retained the pARS plasmid. The assay was duplicated for at least two independently isolated transformants of each strain. RESULTS Replication in ARS603 initiates close to the two ACS elements Previously, we investigated DNA replication events at ARS1 and found that DNA synthesis initiates adjacent to the site of ORC binding (28,29). To determine the DNA replication initiation pattern for ARS603, we performed RIP mapping. This method allowed us to map the start sites for both leading and lagging strand synthesis with nucleotide resolution (30). ARS603 has two core elements, a 10/11 and a 9/11 match to the ACS (27). Here we refer to the first ACS match as A1 and the second ACS match as A2 (Figure 1D
Each ACS match at ARS603 contributes equally to ORC binding Based on our RIP mapping results and earlier studies on ARS603 by others (27), we predicted that ORC binds to A1 and A2. Because this had never been tested directly, and it was unclear whether A1 and A2 could bind a single ORC or multiple complexes, we performed electrophoretic mobility shift analyses on ARS603 using purified ORC. Initially, we titrated ORC to approximate binding of 50% of a ~90 bp probe (data not shown) and used these conditions for subsequent experiments (see Materials and Methods for details). ORC binding to ARS603 was dependent on the presence of ATP (data not shown), as expected (24,35,36). Previous analyses of ARS603 used XhoI substitution mutations that converted the A1 and A2 sequences into 7/11 matches to the ACS. Either mutation at A1 or A2 alone did not affect origin activity; only the combined mutation of both elements resulted in complete loss of activity at ARS603 (27). Using these exact substitutions, here labeled S4, we found that mutations at A1 or A2 caused a decrease in ORC binding in comparison to ORC binding at the WT ARS603 sequence (Figure 3A
Since the XhoI substitution mutations resulted in a gain of GC content, we tested a variety of base substitutions that deviated from the ACS, but kept the GC content of A1 and A2 the same. Not surprisingly, the increase in mismatches to the ACS correlated with the decrease in the amount of shifted probe (Figure 3B Interestingly, however, these 7/11 matches retained much less ORC binding capacity than the 7/11 matches in the S4 A2− and S4 A1− probes (compare Figure 3A and B A single ACS match is insufficient to support ORC binding Although both ACSs in ARS603 appeared to contribute equally to ORC binding, we never detected a second band, even at very high concentrations of ORC (50 nM/reaction, data not shown), as would have been expected if two ORCs could bind to the WT probe. To further define the roles of A1 and A2, we constructed fragments of the same length as the WT ARS603 fragment, containing either element A1 or element A2 flanked by random sequences that were unable to bind ORC by themselves (data not shown). Subsequent in vitro binding assays revealed no significant binding of ORC to either A1 or A2 alone (Figure 4A
ORC binding at ARS603 requires a defined helical phase Examination of the ARS603 sequence revealed that A1 and A2 are separated by 5 bp. Because A1 and A2 lie on opposite strands, this particular spacing would place the two elements on the same side of the DNA double helix. To explore whether this specific configuration is a requirement for ORC binding, we inserted sequences of different lengths between the A1 and A2 elements. The insertion of 5 bp, approximately half a helical turn, caused a severe reduction in ORC binding (Figure 4C A single base pair deletion between the ACS matches in ARS603 and ARS101 abolishes ORC binding Replication initiation at a number of viral origins is severely influenced by the spacing between recognition sites (3,4). Because the configuration of functional elements and associated ACSs varies from one origin to another in budding yeast (37), it is widely assumed that the distance between ACSs is not relevant for origin function. To test this hypothesis directly, we examined the effect of a single bp deletion between A1 and A2. Surprisingly, ORC no longer bound to the ARS603 fragment (Figure 5A
Spacing of bipartite elements at ARS1 and ARS307 does not affect ORC binding The ACS matches in both ARS603 and ARS101 were reported to be redundant with respect to their ability to bind ORC or confer ARS activity (26,27). In contrast to these compound origins, ARS1 and ARS307 contain only a single essential ACS match (the A element). Previous studies showed that the A element is required but not sufficient for ORC binding and that ORC interacts with both the A and B1 elements in ARS1 (18,24,35). To address whether the spacing between A and B1 is crucial for ORC binding at ARS1 and ARS307, we introduced deletion mutations between these elements. These deletions also reduced the spacing between the associated ACSs. ORC binding at both ARS1 and ARS307 was not significantly affected by the removal of a single bp (Figure 5C and E Orientation of the A elements affects ORC binding at ARS603, ARS101 and ARS1 Early comparisons of ARS element configurations revealed that the orientation of ACSs differs from origin to origin (6). This prompted us to investigate whether ORC binding was sensitive to changes in the orientation of individual ACSs at ARS603, ARS101 and ARS1 (Figure 1
ORC binding in vivo reflects ORC binding in vitro Because the in vitro DNA mobility shift assays using purified ORC revealed that the spacing between A1 and A2 was critical for ORC binding at ARS603, we next examined the effect of the single bp deletion in vivo by ChIP using ORC2-specific antibodies. Regardless of whether ARS603 was inserted at the URA3 locus or present at its endogenous locus, a single bp deletion between the A elements abrogated ORC binding in vivo (Figure 7A and C
Origin activation parallels ORC binding So far, we have shown that substitutions within the ACS as well as changes in orientation and spacing between A1 and A2 severely affected ORC binding at ARS603. To test whether these mutations also affected origin activation, we performed plasmid stability assays. These assays require origin sequences to be cloned into plasmids containing the URA3 gene and a centromere sequence (40). Once transformed into yeast, the plasmid constructs are stably retained only with the presence of an active and effective yeast origin. Mitotic stability indicates the ability of the origin to support DNA replication initiation and retain the plasmid, thus allowing for survival in selective medium. Sequences of ~200 bp covering the entire ARS603 region were used to test origin activity. WT ARS1 served as a positive control, and ARS1/A− served as a negative control. The pARS1/A− construct did not produce viable transformants that could be restreaked onto selective medium, as reported earlier (14). The level of origin activity in vivo correlated well with ORC binding in vitro in all cases examined (Figure 8A
DISCUSSION Analysis of ARS603 provides a new perspective on the contribution of both DNA sequence and structure to origin function. Because no two origins of DNA replication are identical, it has been difficult to understand what distinguishes functional from non-functional ACSs. Examination of the structural framework necessary for ORC binding in budding yeast provides clues to the complex nature of its interaction with DNA. In this study, we demonstrate that while two ACSs at ARS603 contribute equally to ORC binding, they cannot function independently. The ACSs at ARS603 require a restricted alignment to form a functional ORC binding site, and it is reasonable to assume that this may apply to other loci besides ARS603 in the yeast genome. Two classes of origins in budding yeast In the course of defining the parameters that allow for the efficient binding of ORC to ARS603, we discovered that the interdomain spacing between A1 and A2 is critically important. This phenomenon was not found to be unique to ARS603 since binding of ORC to ARS101 was also responsive to single bp interdomain deletions. At the same time, not all of the origins we tested were affected by such changes, as ARS1 and ARS307 did not show any significant loss of ORC binding. Therefore, we propose that two classes of origins exist in yeast: those that require exact interdomain spacing and those that are tolerant of spacing manipulation. These differences directly reflect two different modes of ORC binding. In ARS603, the two ACSs that constitute the bipartite ORC binding site appear to contribute equally to ORC binding, whereas the A element in ARS1 appears to be the predominant site of ORC interaction (41). Furthermore, it is possible that other ORC-interacting proteins modulate the affinity of ORC for certain sites in the genome. Indeed, previous studies have found that another replication initiation protein, Cdc6, regulates the sequence-specific binding of ORC at ARS1 (42,43). It will be interesting to see whether Cdc6-dependent regulation is characteristic for this class of origins or also applies to ARS603 and ARS101. ORC binding at bipartite sites Previous studies suggested that ORC could bind to a bipartite site comprised of A and B1 elements (ARS1 and 307) (14,15,18,26). However, prior evaluations of origin function also described the discovery of origins with multiple ACSs with redundant function (26). These origins were named compound if they contained redundant ACSs that were proposed to function as individual ORC binding sites (26). Our study on ARS603 reconciles these two origin models. Although ARS603 contains two ACSs (A1 and A2), we concluded from our results that these two elements are not acting as binding sites for separate ORCs but rather as a bipartite binding site for a single initiator complex. This may also apply to ARS101 because the deletion of a single bp between the ACSs, as well as changes in their orientation, abolished ORC binding in vitro. In addition, ARS101 activity was markedly reduced when one ACS was mutated, arguing that ORC strongly prefers to bind to both ACSs (26). At first glance, our results seem to contradict the finding by Theis and Newlon that the 10/11 match in ARS101 can retain ARS activity by itself (26). However, further inspection of the ARS101 sequence reveals two additional 8/11 matches downstream of the 10/11 ACS element (data not shown). It is conceivable that one of these 8/11 matches cooperated with the 10/11 match to form a bipartite ORC binding site. Consistent with this notion, we show that a single A element in ARS603, another compound origin, cannot sustain ORC binding. These data are in agreement with early reports that the 11 bp ACS is necessary but not sufficient for ARS activity (44). This is further supported by the fact that substitution mutations at ARS101 showed the gain of new hypersensitive sites with the loss of one ACS element (26), indicating that ORC contacted a second site in close proximity to the remaining A element. At ARS1 as well, footprinting studies showed that mutation of the A element resulted in protection over a 9/11 ACS at an additional B element (24,35), consistent with the recovery of a bipartite site. Indeed, in vitro studies determined that two ORCs cannot bind to two inverted ACSs at ARS1 simultaneously (24,45), and other studies have determined that the stoichiometry of ORC to the ARS1 origin is 1:1 (46). It follows that the recognition of a bipartite binding site with two ACSs by a single ORC likely applies to the vast majority of origins in the yeast genome. In addition, fluorescence anisotropy studies showed that ORC is capable of binding to ACS matches associated with various elements of ARS1 (47); however, only with the presence of the A element was ORC binding dependent on ATP, a key factor in the sequence-specific recognition of ORC at origins (24,35,36). Therefore, it seems likely that certain ORC conformations dictated by the spatial arrangements of ACSs may either allow or restrict ATP-hydrolysis by ORC (48). It is conceivable that the single bp deletion between A1 and A2 in ARS603, or the reversal of A elements in ARS1, ARS101 and ARS603, induced an ORC conformation that failed to repress ATP-hydrolysis by ORC and did not facilitate stable binding to DNA (36,49). As a heteromultimer protein complex (24), ORC subunits possess the potential to make contact at an origin in a variety of ways. Modification-interference and missing-contact assays at ARS1 and ARS305 provided the first look at the diverse nature of the ORC-origin interaction (41). While ORC contacts in ARS305 were discerned within a ~50 bp region, ORC coverage at ARS1 extended to a ~92 bp range (41). Footprinting and mobility shift studies also support the ability of DNA sequences to wrap around ORC, enabling it to contact multiple regions at wide ranges (14,18). Thus, it is possible for ORC to make contact with sequences over a long distance. However, ORC may possess limited adaptability, resulting in the selection of certain bipartite sites and providing one explanation for why the yeast genome harbors only ~430 ORC binding sites, but has more than 10 000 ACS matches (19).In a recent model for the prediction of functional origins in budding yeast, Breier et al. devised an Oriscan algorithm based on the alignment of a subset of known origins to the extended 17 bp ACS (20,21). This algorithm was based on the assumption that a single extended ACS (20) in conjunction with certain flanking regions could function as an ORC binding site and did not fully take into account the bipartite structure of replication origins in yeast (18). We propose a revised algorithm definition to include two matches to the ACS as a bipartite binding site for ORC, as previous studies have also shown that synthetic constructs with two copies of the ACS are sufficient for ARS activity (6). Moreover, it is known that the presence of additional ACSs further improve origin function (6,45). This definition does not preclude the use of the extended 17 bp ACS (20). Prior analyses of the region between the A and B1 elements (and thus between the corresponding ACSs) of ARS1 indicated that an insertion of 195 bp or greater essentially inactivated ARS activity (38). Inspection of nine origins on chromosome VI with identified, essential ACSs (27,50) revealed that a second ACS (with a 9/11 match or better) resides in close proximity, at a distance of at most 119 bp (data not shown). On average, we calculated the distance to be 38 ± 35 bp (data not shown). We suggest that these considerations might provide a framework for the definition of a functional ORC binding site. Clearly, further studies are needed to test the validity of this hypothesis. Phylogenetic comparisons of conserved sequences may contribute to these endeavors (51). Bipartite structures for origin recognition in other organisms Our studies demonstrate that the spacing of the bipartite ORC binding site affects the origin activity of ARS603. Replication mechanisms in a number of prokaryotes and viruses show similarity to mechanisms employed at the eukaryotic origins of budding yeast (1). In fact, the recognition of a bipartite binding site for the initiation of bi-directional replication is a familiar theme that is seen in bacterial and viral systems, such as at oriP of Epstein-Barr virus and the core origin of SV40 (2). In Escherichia coli, ATP-dependent origin activation relies on the presence of two out of the multiple 9-mers that comprise oriC, consistent with the recognition of a bipartite site (52). Precise spacing of sequences at the dyad symmetry element DS within oriP is required for interaction with EBNA1 in Epstein-Barr virus where origin activity is abolished with the deletion of 1 to 2 bp (3). Likewise, spacing affects binding of the SV40 initiator, large T-antigen, at site II that requires a minimum of 10 bp between two pairs of pentanucleotides with inward orientation (4). According to our results, the A elements at ARS603 appear to function similarly with a requirement for defined spacing and helical phasing. Some evidence exists to suggest the conservation of a bipartite site in other eukaryotes as well. For instance, footprinting analyses of a metazoan replication origin, ori II/9A, in Sciara coprophila using nuclear extract and purified ORC, show two separate regions of protection for ORC binding (53). Furthermore, recent ChIP studies at the human c-myc replicator suggest that ORC binds to two distinct AT-rich regions, resulting in a bipartite binding pattern (54). Thus, the use of a bipartite binding site for the initiator appears to be another connection in the mechanism for the initiation of DNA replication in multiple organisms. Acknowledgments The authors are grateful to B. Stillman for baculovirus-purified yeast ORC, the SP1 strain and the pARS plasmid. The authors would also like to thank S. P. Bell for baculovirus-purified yeast ORC and protocols, and D. Clarke for the BF264-15DU strain. In addition, The authors thank D. M. Livingston, J. Theis and the Bielinsky lab members for advice and protocols, as well as E. A. Hendrickson for critical reading of the manuscript. This work was supported by ACS grant RSG0216601 to AKB. Funding to pay the Open Access publication charges for this article was provided by the American Cancer Society. Conflict of interest statement. None declared. REFERENCES 1. Stillman B. Comparison of DNA Replication in Cells from Prokarya and Eukarya. In: DePamphilis M.L., editor. DNA Replication in Eukaryotic Cells. Cold Spring Harbor, NY: CSHL press; 1996. pp. 435–460. 2. Wang J., Sugden B. Origins of bidirectional replication of Epstein–Barr virus: models for understanding mammalian origins of DNA synthesis. J. Cell. Biochem. 2005;94:247–256. [PubMed] 3. Bashaw J.M., Yates J.L. Replication from oriP of Epstein–Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J. Virol. 2001;75:10603–10611. [PubMed] 4. Joo W.S., Luo X., Denis D., Kim H.Y., Rainey G.J., Jones C., Sreekumar K.R., Bullock P.A. Purification of the simian virus 40 (SV40) T antigen DNA-binding domain and characterization of its interactions with the SV40 origin. J. Virol. 1997;71:3972–3985. [PubMed] 5. Aladjem M.I., Fanning E. The replicon revisited: an old model learns new tricks in metazoan chromosomes. EMBO Rep. 2004;5:686–691. [PubMed] 6. Palzkill T.G., Newlon C.S. A yeast replication origin consists of multiple copies of a small conserved sequence. Cell. 1988;53:441–450. [PubMed] 7. Deshpande A.M., Newlon C.S. The ARS consensus sequence is required for chromosomal origin function in Saccharomyces cerevisiae. Mol. Cell. Biol. 1992;12:4305–4313. [PubMed] 8. Newlon C.S., Theis J.F. The structure and function of yeast ARS elements. Curr. Opin. Genet. Dev. 1993;3:752–758. [PubMed] 9. Van Houten J.V., Newlon C.S. Mutational analysis of the consensus sequence of a replication origin from yeast chromosome III. Mol. Cell. Biol. 1990;10:3917–3925. [PubMed] 10. Broach J.R., Li Y.Y., Feldman J., Jayaram M., Abraham J., Nasmyth K.A., Hicks J.B. Localization and sequence analysis of yeast origins of DNA replication. Cold Spring Harb. Symp. Quant. Biol. 1983;47:1165–1173. [PubMed] 11. Walker S.S., Malik A.K., Eisenberg S. Analysis of the interactions of functional domains of a nuclear origin of replication from Saccharomyces cerevisiae. Nucleic Acids Res. 1991;19:6255–6262. [PubMed] 12. Bouton A.H., Smith M.M. Fine-structure analysis of the DNA sequence requirements for autonomous replication of Saccharomyces cerevisiae plasmids. Mol. Cell. Biol. 1986;6:2354–2363. [PubMed] 13. Huang R.Y., Kowalski D. Multiple DNA elements in ARS305 determine replication origin activity in a yeast chromosome. Nucleic Acids Res. 1996;24:816–823. [PubMed] 14. Marahrens Y., Stillman B. A yeast chromosomal origin of DNA replication defined by multiple functional elements. Science. 1992;255:817–823. [PubMed] 15. Theis J.F., Newlon C.S. Domain B of ARS307 contains two functional elements and contributes to chromosomal replication origin function. Mol. Cell. Biol. 1994;14:7652–7659. [PubMed] 16. Marahrens Y., Stillman B. Replicator dominance in a eukaryotic chromosome. EMBO J. 1994;13:3395–3400. [PubMed] 17. Rao H., Marahrens Y., Stillman B. Functional conservation of multiple elements in yeast chromosomal replicators. Mol. Cell. Biol. 1994;14:7643–7651. [PubMed] 18. Rao H., Stillman B. The origin recognition complex interacts with a bipartite DNA binding site within yeast replicators. Proc. Natl Acad. Sci. USA. 1995;92:2224–2228. [PubMed] 19. Wyrick J.J., Aparicio J.G., Chen T., Barnett J.D., Jennings E.G., Young R.A., Bell S.P., Aparicio O.M. Genome-wide distribution of ORC and MCM proteins in S.cerevisiae: high-resolution mapping of replication origins. Science. 2001;294:2357–2360. [PubMed] 20. Theis J.F., Newlon C.S. The ARS309 chromosomal replicator of Saccharomyces cerevisiae depends on an exceptional ARS consensus sequence. Proc. Natl Acad. Sci. USA. 1997;94:10786–10791. [PubMed] 21. Breier A.M., Chatterji S., Cozzarelli N.R. Prediction of Saccharomyces cerevisiae replication origins. Genome Biol. 2004;5:R22. [PubMed] 22. Diffley J.F.X., Cocker J.H., Dowell S.J., Rowley A. Two steps in the assembly of complexes at yeast replication origins in vivo. Cell. 1994;78:303–316. [PubMed] 23. Diffley J.F.X., Cocker J.H., Dowell S.J., Harwood J., Rowley A. Stepwise assembly of initiation complexes at budding yeast replication origins during the cell cycle. J. Cell. Sci. Suppl. 1995;19:67–72. [PubMed] 24. Bell S.P., Stillman B. ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex. Nature. 1992;357:128–134. [PubMed] 25. Hurst S.T., Rivier D.H. Identification of a compound origin of replication at the HMR-E locus in Saccharomyces cerevisiae. J. Biol. Chem. 1999;274:4155–4159. [PubMed] 26. Theis J.F., Newlon C.S. Two compound replication origins in Saccharomyces cerevisiae contain redundant origin recognition complex binding sites. Mol. Cell. Biol. 2001;21:2790–2801. [PubMed] 27. Shirahige K., Iwasaki T., Rashid M.B., Ogasawara N., Yoshikawa H. Location and characterization of autonomously replicating sequences from chromosome VI of Saccharomyces cerevisiae. Mol. Cell. Biol. 1993;13:5043–5056. [PubMed] 28. Bielinsky A.K., Gerbi S.A. Discrete start sites for DNA synthesis in the yeast ARS1 origin. Science. 1998;279:95–98. [PubMed] 29. Bielinsky A.K., Gerbi S.A. Chromosomal ARS1 has a single leading strand start site. Mol. Cell. 1999;3:477–486. [PubMed] 30. Gerbi S.A., Bielinsky A.K. Replication initiation point mapping. Methods. 1997;13:271–280. [PubMed] 31. Palacios DeBeer M.A., Muller U., Fox C.A. Differential DNA affinity specifies roles for the origin recognition complex in budding yeast heterochromatin. Genes Dev. 2003;17:1817–1822. [PubMed] 32. Richardson H.E., Wittenberg C., Cross F., Reed S.I. An essential G1 function for cyclin-like proteins in yeast. Cell. 1989;59:1127–1133. [PubMed] 33. Strahl-Bolsinger S., Hecht A., Luo K., Grunstein M. SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. Genes Dev. 1997;11:83–93. [PubMed] 34. Lucca C., Vanoli F., Cotta-Ramusino C., Pellicioli A., Liberi G., Haber J., Foiani M. Checkpoint-mediated control of replisome-fork association and signalling in response to replication pausing. Oncogene. 2004;23:1206–1213. [PubMed] 35. Rowley A., Cocker J.H., Harwood J., Diffley J.F.X. Initiation complex assembly at budding yeast replication origins begins with the recognition of a bipartite sequence by limiting amounts of the initiator, ORC. EMBO J. 1995;14:2631–2641. [PubMed] 36. Klemm R.D., Austin R.J., Bell S.P. Coordinate binding of ATP and origin DNA regulates the ATPase activity of the origin recognition complex. Cell. 1997;88:493–502. [PubMed] 37. Lin S., Kowalski D. Functional equivalency and diversity of cis-acting elements among yeast replication origins. Mol. Cell. Biol. 1997;17:5473–5484. [PubMed] 38. Diffley J.F., Stillman B. Purification of a yeast protein that binds to origins of DNA replication and a transcriptional silencer. Proc. Natl Acad. Sci. USA. 1988;85:2120–2124. [PubMed] 39. Holmes S.G., Smith M.M. Interaction of the H4 autonomously replicating sequence core consensus sequence and its 3′-flanking domain. Mol. Cell. Biol. 1989;9:5464–5472. [PubMed] 40. Stinchcomb D.T., Struhl K., Davis R.W. Isolation and characterisation of a yeast chromosomal replicator. Nature. 1979;282:39–43. [PubMed] 41. Lee D.G., Bell S.P. Architecture of the yeast origin recognition complex bound to origins of DNA replication. Mol. Cell. Biol. 1997;17:7159–7168. [PubMed] 42. Speck C., Chen Z., Li H., Stillman B. ATPase-dependent cooperative binding of ORC and Cdc6 to origin DNA. Nature Struct. Mol. Biol. 2005;12:965–971. [PubMed] 43. Mizushima T., Takahashi N., Stillman B. Cdc6p modulates the structure and DNA binding activity of the origin recognition complex in vitro. Genes Dev. 2000;14:1631–1641. [PubMed] 44. Celniker S.E., Sweder K., Srienc F., Bailey J.E., Campbell J.L. Deletion mutations affecting autonomously replicating sequence ARS1 of Saccharomyces cerevisiae. Mol. Cell. Biol. 1984;4:2455–2466. [PubMed] 45. Wilmes G.M., Bell S.P. The B2 element of the Saccharomyces cerevisiae ARS1 origin of replication requires specific sequences to facilitate pre-RC formation. Proc. Natl Acad. Sci. USA. 2002;99:101–106. [PubMed] 46. Chastain P.D., 2nd, Bowers J.L., Lee D.G., Bell S.P., Griffith J.D. Mapping subunit location on the Saccharomyces cerevisiae origin recognition complex free and bound to DNA using a novel nanoscale biopointer. J. Biol. Chem. 2004;279:36354–36362. [PubMed] 47. Biswas S.B., Khopde S.M., Biswas-Fiss E.E. Control of ATP-dependent binding of Saccharomyces cerevisiae origin recognition complex to autonomously replicating DNA sequences. Cell Cycle. 2005;4:494–500. [PubMed] 48. Lee D.G., Bell S.P. ATPase switches controlling DNA replication initiation. Curr. Opin. Cell. Biol. 2000;12:280–285. [PubMed] 49. Makise M., Takenaka H., Kuwae W., Takahashi N., Tsuchiya T., Mizushima T. Kinetics of ATP binding to the origin recognition complex of Saccharomyces cerevisiae. J. Biol. Chem. 2003;278:46440–46445. [PubMed] 50. Friedman K.L., Brewer B.J., Fangman W.L. Replication profile of Saccharomyces cerevisiae chromosome VI. Genes Cells. 1997;2:667–678. [PubMed] 51. Nieduszynski C.A., Knox Y., Donaldson A.D. Genome-wide identification of replication origins in yeast by comparative genomics. Genes Dev. 2006;20:1874–1879. [PubMed] 52. McGarry K.C., Ryan V.T., Grimwade J.E., Leonard A.C. Two discriminatory binding sites in the Escherichia coli replication origin are required for DNA strand opening by initiator DnaA-ATP. Proc. Natl Acad. Sci. USA. 2004;101:2811–2816. [PubMed] 53. Bielinsky A.K., Blitzblau H., Beall E.L., Ezrokhi M., Smith H.S., Botchan M.R., Gerbi S.A. Origin recognition complex binding to a metazoan replication origin. Curr. Biol. 2001;11:1427–1431. [PubMed] 54. Ghosh M., Kemp M., Liu G., Ritzi M., Schepers A., Leffak M. Differential binding of replication proteins across the human c-myc replicator. Mol. Cell Biol. 2006;26:5270–5283. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
J Cell Biochem. 2005 Feb 1; 94(2):247-56.
[J Cell Biochem. 2005]J Virol. 2001 Nov; 75(22):10603-11.
[J Virol. 2001]J Virol. 1997 May; 71(5):3972-85.
[J Virol. 1997]EMBO Rep. 2004 Jul; 5(7):686-91.
[EMBO Rep. 2004]Cell. 1988 May 6; 53(3):441-50.
[Cell. 1988]Curr Opin Genet Dev. 1993 Oct; 3(5):752-8.
[Curr Opin Genet Dev. 1993]Cold Spring Harb Symp Quant Biol. 1983; 47 Pt 2():1165-73.
[Cold Spring Harb Symp Quant Biol. 1983]Nucleic Acids Res. 1991 Nov 25; 19(22):6255-62.
[Nucleic Acids Res. 1991]Mol Cell Biol. 1994 Nov; 14(11):7652-9.
[Mol Cell Biol. 1994]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Cell. 1994 Jul 29; 78(2):303-16.
[Cell. 1994]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]J Biol Chem. 1999 Feb 12; 274(7):4155-9.
[J Biol Chem. 1999]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Science. 1998 Jan 2; 279(5347):95-8.
[Science. 1998]Mol Cell. 1999 Apr; 3(4):477-86.
[Mol Cell. 1999]Mol Cell. 1999 Apr; 3(4):477-86.
[Mol Cell. 1999]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Methods. 1997 Nov; 13(3):271-80.
[Methods. 1997]Genes Dev. 2003 Aug 1; 17(15):1817-22.
[Genes Dev. 2003]Cell. 1989 Dec 22; 59(6):1127-33.
[Cell. 1989]Genes Dev. 1997 Jan 1; 11(1):83-93.
[Genes Dev. 1997]Oncogene. 2004 Feb 12; 23(6):1206-13.
[Oncogene. 2004]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Science. 1998 Jan 2; 279(5347):95-8.
[Science. 1998]Mol Cell. 1999 Apr; 3(4):477-86.
[Mol Cell. 1999]Methods. 1997 Nov; 13(3):271-80.
[Methods. 1997]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]EMBO J. 1995 Jun 1; 14(11):2631-41.
[EMBO J. 1995]Cell. 1997 Feb 21; 88(4):493-502.
[Cell. 1997]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]Curr Opin Genet Dev. 1993 Oct; 3(5):752-8.
[Curr Opin Genet Dev. 1993]Nucleic Acids Res. 1996 Mar 1; 24(5):816-23.
[Nucleic Acids Res. 1996]Mol Cell Biol. 1994 Nov; 14(11):7652-9.
[Mol Cell Biol. 1994]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]J Virol. 2001 Nov; 75(22):10603-11.
[J Virol. 2001]J Virol. 1997 May; 71(5):3972-85.
[J Virol. 1997]Mol Cell Biol. 1997 Sep; 17(9):5473-84.
[Mol Cell Biol. 1997]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]EMBO J. 1995 Jun 1; 14(11):2631-41.
[EMBO J. 1995]Cell. 1988 May 6; 53(3):441-50.
[Cell. 1988]Proc Natl Acad Sci U S A. 1988 Apr; 85(7):2120-4.
[Proc Natl Acad Sci U S A. 1988]Mol Cell Biol. 1989 Dec; 9(12):5464-72.
[Mol Cell Biol. 1989]Nature. 1979 Nov 1; 282(5734):39-43.
[Nature. 1979]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Mol Cell Biol. 1997 Dec; 17(12):7159-68.
[Mol Cell Biol. 1997]Nat Struct Mol Biol. 2005 Nov; 12(11):965-71.
[Nat Struct Mol Biol. 2005]Genes Dev. 2000 Jul 1; 14(13):1631-41.
[Genes Dev. 2000]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Mol Cell Biol. 1994 Nov; 14(11):7652-9.
[Mol Cell Biol. 1994]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Mol Cell Biol. 1984 Nov; 4(11):2455-66.
[Mol Cell Biol. 1984]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]EMBO J. 1995 Jun 1; 14(11):2631-41.
[EMBO J. 1995]Proc Natl Acad Sci U S A. 2002 Jan 8; 99(1):101-6.
[Proc Natl Acad Sci U S A. 2002]J Biol Chem. 2004 Aug 27; 279(35):36354-62.
[J Biol Chem. 2004]Cell Cycle. 2005 Mar; 4(3):494-500.
[Cell Cycle. 2005]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]EMBO J. 1995 Jun 1; 14(11):2631-41.
[EMBO J. 1995]Cell. 1997 Feb 21; 88(4):493-502.
[Cell. 1997]Curr Opin Cell Biol. 2000 Jun; 12(3):280-5.
[Curr Opin Cell Biol. 2000]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]Mol Cell Biol. 1997 Dec; 17(12):7159-68.
[Mol Cell Biol. 1997]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Science. 2001 Dec 14; 294(5550):2357-60.
[Science. 2001]Proc Natl Acad Sci U S A. 1997 Sep 30; 94(20):10786-91.
[Proc Natl Acad Sci U S A. 1997]Genome Biol. 2004; 5(4):R22.
[Genome Biol. 2004]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Cell. 1988 May 6; 53(3):441-50.
[Cell. 1988]Proc Natl Acad Sci U S A. 2002 Jan 8; 99(1):101-6.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 1988 Apr; 85(7):2120-4.
[Proc Natl Acad Sci U S A. 1988]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Genes Cells. 1997 Nov; 2(11):667-78.
[Genes Cells. 1997]Genes Dev. 2006 Jul 15; 20(14):1874-9.
[Genes Dev. 2006]J Cell Biochem. 2005 Feb 1; 94(2):247-56.
[J Cell Biochem. 2005]Proc Natl Acad Sci U S A. 2004 Mar 2; 101(9):2811-6.
[Proc Natl Acad Sci U S A. 2004]J Virol. 2001 Nov; 75(22):10603-11.
[J Virol. 2001]J Virol. 1997 May; 71(5):3972-85.
[J Virol. 1997]Curr Biol. 2001 Sep 18; 11(18):1427-31.
[Curr Biol. 2001]Mol Cell Biol. 2006 Jul; 26(14):5270-83.
[Mol Cell Biol. 2006]Science. 1992 Feb 14; 255(5046):817-23.
[Science. 1992]Mol Cell Biol. 1994 Nov; 14(11):7652-9.
[Mol Cell Biol. 1994]Mol Cell Biol. 1994 Nov; 14(11):7643-51.
[Mol Cell Biol. 1994]Mol Cell Biol. 2001 Apr; 21(8):2790-801.
[Mol Cell Biol. 2001]Mol Cell Biol. 1993 Aug; 13(8):5043-56.
[Mol Cell Biol. 1993]Proc Natl Acad Sci U S A. 1995 Mar 14; 92(6):2224-8.
[Proc Natl Acad Sci U S A. 1995]Oncogene. 2004 Feb 12; 23(6):1206-13.
[Oncogene. 2004]